John Henderson
Förmögenhet: 6 M $ per 2026-07-31
Förmögenhet: 6 M $ per 2026-07-31
John Tannahill Henderson is Chairman at Cytokinetics, Inc. since 2022, with employment at the firm starting in 2009.
Former roles include Chairman at Asmacure Ltée; Independent Director at Myriad Genetics, Inc. in 2020; Non-Executive Director at Inveresk Research Group, Inc.; Independent Director at Myrexis, Inc. from 2011 to 2013; Vice President at Pfizer Pharmaceuticals, Inc.; President at Futurepharm LLC; Chief Development Officer at NeuroVia, Inc.; and VP-Europe, US & International Pharmaceuticals at Pfizer Inc. Education includes undergraduate and doctorate degrees from The University of Edinburgh.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-15 | 78 443 ( 0,06 % ) | 6 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Ordförande | 2022-04-08 |
| Företag | Position | Slut |
|---|---|---|
| MYRIAD GENETICS, INC. | Ordförande | 2020-03-23 |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Företagsledare/Principal | 2018-10-01 |
| MYREXIS, INC. | Direktör/Styrelseledamot | 2013-01-01 |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | 2000-12-01 |
| PFIZER INC. | Företagsledare/Principal | 2000-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Myrexis, Inc.
Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asmacure Ltée
Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån